# A Analgesic Study of Adductor Canal &IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty

> **NCT06145165** · PHASE4 · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Liposomal Bupivacaine
- Postoperative Recovery
- Unilateral Knee Arthroplasty

## Interventions

- **OTHER:** Nerve block with ropivacaine and intravenous analgesia
- **COMBINATION_PRODUCT:** Nerve block with liposomal bupivacaine and intravenous analgesia
- **OTHER:** Intravenous analgesia

## Key facts

- **NCT ID:** NCT06145165
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06145165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06145165, "A Analgesic Study of Adductor Canal &IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06145165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*